These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 23021659

  • 21. Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?
    Pascale A, Serfaty L.
    J Hepatol; 2013 Feb; 58(2):391-4. PubMed ID: 23063419
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Optimal treatment with telaprevir for chronic HCV infection.
    Jesudian AB, Jacobson IM.
    Liver Int; 2013 Feb; 33 Suppl 1():3-13. PubMed ID: 23286840
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dynamic changes in HCV RNA levels and viral quasispecies in a patient with chronic hepatitis C after telaprevir-based treatment.
    de Bruijne J, Sullivan JC, Kieffer TL, Botfield M, Shames B, Schinkel J, Molenkamp R, Weegink C, Reesink H.
    J Clin Virol; 2012 Feb; 53(2):174-7. PubMed ID: 22138301
    [Abstract] [Full Text] [Related]

  • 32. New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.
    Dusheiko G, Wedemeyer H.
    Gut; 2012 Dec; 61(12):1647-52. PubMed ID: 22936671
    [No Abstract] [Full Text] [Related]

  • 33. Treatment of hepatitis C monoinfection in adults--Dutch national guidelines.
    Lamers MH, Broekman MM, Boucher CA, Brouwer JT, Burger DM, van Hoek B, Hoepelman AI, de Knegt RJ, Reesink HW, Drenth JP, Netherlands Association of Hepato-gastroenterologists, Netherlands Association of Internal Medicine, Dutch Association for the Study of Liver Disease.
    Neth J Med; 2013 Sep; 71(7):377-85. PubMed ID: 24038567
    [Abstract] [Full Text] [Related]

  • 34. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.
    Reddy KR, Zeuzem S, Zoulim F, Weiland O, Horban A, Stanciu C, Villamil FG, Andreone P, George J, Dammers E, Fu M, Kurland D, Lenz O, Ouwerkerk-Mahadevan S, Verbinnen T, Scott J, Jessner W.
    Lancet Infect Dis; 2015 Jan; 15(1):27-35. PubMed ID: 25482330
    [Abstract] [Full Text] [Related]

  • 35. Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in treatment-experienced chronic hepatitis C genotype 1 patients.
    Cure S, Bianic F, Gavart S, Curtis S, Lee S, Dusheiko G.
    J Med Econ; 2014 Jan; 17(1):77-87. PubMed ID: 24032626
    [Abstract] [Full Text] [Related]

  • 36. Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
    Shiffman ML, Esteban R.
    Liver Int; 2012 Feb; 32 Suppl 1():54-60. PubMed ID: 22212573
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Use of boceprevir and telaprevir in patients with hepatitis C virus infection (practical considerations)].
    Crespo G, Lens S.
    Gastroenterol Hepatol; 2012 May; 35(5):337-43. PubMed ID: 22349607
    [Abstract] [Full Text] [Related]

  • 40. Telaprevir for the treatment of chronic hepatitis C infection.
    Muir AJ.
    Expert Rev Anti Infect Ther; 2011 Dec; 9(12):1105-14. PubMed ID: 22114960
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.